RecruitingPhase 2NCT06940011

Endocalyx in Treatment Resistent Hypertension

Glycocalyx Restoration in Treatment Resistant Hypertension: a Proof of Concept, Randomized, Double-blind, Placebo-controlled Study


Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Enrollment

64 participants

Start Date

Jan 21, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this randomized, double-blind, placebo-controlled study is to assess whether the food supplement Endocalyx lowers blood pressure in patients with treatment resistant hypertension.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a supplement called Endocalyx — which aims to support the lining of blood vessels — can help lower blood pressure in people with treatment-resistant hypertension. Treatment-resistant hypertension means blood pressure is still dangerously high despite taking three or more blood pressure medications at optimal doses. **You may be eligible if...** - Your blood pressure remains above 140/90 mmHg despite taking at least 3 different blood pressure medications, including a diuretic (water pill), at maximum tolerated doses - Your medications have been stable for the past 3 weeks - You have signed informed consent **You may NOT be eligible if...** - You are under 18 years old - Your kidney function is severely reduced (eGFR below 20) - Your blood pressure is extremely high (systolic above 180 or diastolic above 110) - You have a known secondary cause for your high blood pressure (e.g., a hormonal condition) - You have had a recent heart attack, stroke, or major surgery - You were recently hospitalized for heart failure - You are pregnant or not using adequate contraception Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTEndocalyx Pro

4 capsules once daily OR 2 capsules twice daily

OTHERPlacebo

4 capsules once daily OR 2 capsules twice daily


Locations(1)

Amsterdam UMC

Amsterdam, North Holland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06940011


Related Trials